LobbyingGinkgo Bioworks lobbying by quarter
Ginkgo Bioworks DNA's latest lobbying report covers Q2 2026, at $120K. The four quarters Q3 2025–Q2 2026 total $390K. Its first report covers Q4 2022; the issues it reports most are Defense and Medical/Disease Research/Clinical Labs.
Ginkgo BioworksDNA
- Latest quarter
- $120K
- Q2 2026 · 2 reports
- Last 12 months
- $390K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $90K | 2 |
| Q1 2023 | $180K | 5 |
| Q2 2023 | $180K | 5 |
| Q3 2023 | $140K | 3 |
| Q4 2023 | $130K | 3 |
| Q1 2024 | $120K | 3 |
| Q2 2024 | $90K | 3 |
| Q3 2024 | $90K | 3 |
| Q4 2024 | $70K | 3 |
| Q1 2025 | $60K | 2 |
| Q2 2025 | $70K | 2 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $90K | 2 |
| Q1 2026 | $120K | 2 |
| Q2 2026 | $120K | 2 |
Policy issues the reports name
- Defense21 reports
- Medical research and clinical labs18 reports
- Budget and appropriations14 reports
- Agriculture10 reports
- Health issues6 reports
- Foreign relations4 reports
- Science and technology4 reports
- Natural resources1 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES35 reports
- SENATE35 reports
- Defense, Dept of (DOD)14 reports
- Agriculture, Dept of (USDA)12 reports
- Health & Human Services, Dept of (HHS)9 reports
- State, Dept of (DOS)4 reports
- U.S. Agency for International Development (USAID)4 reports
- Executive Office of the President (EOP)3 reports
- Office of Management & Budget (OMB)3 reports
- Energy, Dept of2 reports
- White House Office2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Cornerstone Government Affairs | $1.1M | 14 quarters |
| Forbes-Tate | $270K | 10 quarters |
| Crossroads Strategies | $150K | 3 quarters |
| Kyle House Group | $70K | 8 quarters |
| Horizons Global Solutions | $60K | 3 quarters |
| Government Solutions | $10K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| KARYN RICHMAN | Program Examiner, Executive Office of the President, Office of Management and Budget; Professional Staff, House Appropriations Committee | Q2 2026 |
| WENDY SAMMONS-JACKSON | Director, Military Infectious Diseases Research Program, US Army Medical Research and Development Command | Q2 2026 |
| SALIM ALAMEDDIN | Legislative Asst/Legislative Aide, Rep. Will Hurd; Legislative Correspondent/Staff Asst, Sen. John Cornyn | Q1 2026 |
| STEPHEN THOMAS VOLJAVEC | Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn | Q1 2026 |
| WESLEY RYAN WELCH | Legislative Director, Sen. Richard Shelby (2005-2007); Legislative Assistant, Sen. Richard Shelby (2002-2005) | Q2 2025 |
| SARAH VENUTO | Senior Advisor (Manchin); Counsel, Comm Energy & Natural Resources Chief Counsel; Chief Counsel (Manchin); Staff Director, Comm on Energy & Natural Resources; Director, Office of External Affairs, Federal Energy Regulatory Commission | Q4 2024 |
| ANTHONY LAZARSKI | Senior Legislative Advisor, Senate Member Office (Inhofe); Professional Staff Member, Senate Armed Services Committee; Military Legislative Assistant, Senate Member Office (Inhofe) | Q4 2023 |
| MICHAEL MILLER | Policy Director, U.S. Senate Committee on Foreign Relations; Senior Advisor, Office of the U.S. Secretary HHS; Deputy Assistant Administrator for Global Health, USAID; Director for African Affairs,NSC; Legislative Assistant, Senator Bill Frist | Q4 2023 |
| WILLIAM SMITH | Staff Director, House Approps Cmte; Deputy Staff Director, House Approps Cmte; Chief of Staff, Legislative Director, Senior Legislative Assist, House Member Office (Rogers); Staff Assistant, Senate Approps Cmte | Q4 2023 |
| DAVID FORREST LASSETER | Former Schedule C (DOD, DOJ), Former Congressional Aide (U.S. House, U.S. Senate) | Q3 2023 |
| SAMANTHA MCLEAN | Senior LA, Senator Cruz (2018-2023); LA, Senator Cruz (2016-2018); Leg Aid, Senator Cruz (2013-2016); Assistant to the CoS and LD, Senator Cruz (2013-2013); SA, Senator DeMint (2012-2012). | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/18for Q2 | Crossroads Strategies | $60K |
| 07/10for Q2 | Cornerstone Government Affairs | $60K |
| 04/20for Q1 | Crossroads Strategies | $60K |
| 04/15for Q1 | Cornerstone Government Affairs | $60K |
| 01/20for Q4 2025 | Crossroads Strategies | $30K |
| 01/16for Q4 2025 | Cornerstone Government Affairs | $60K |
| 25/12/11for Q4 2025 | Crossroads Strategies | Under $5,000 |
| 25/10/15for Q3 2025 | Cornerstone Government Affairs | $60K |
| 25/07/16for Q2 2025 | Cornerstone Government Affairs | $60K |
| 25/06/18for Q2 2025 | Forbes-Tate | $10K |
| 25/04/16for Q1 2025 | Cornerstone Government Affairs | $60K |
| 25/04/15for Q1 2025 | Forbes-Tate | Under $5,000 |
| 25/01/21for Q4 2024 | Kyle House Group | Under $5,000 |
| 25/01/20for Q4 2024 | Cornerstone Government Affairs | $70K |
| 25/01/19for Q4 2024 | Forbes-Tate | Under $5,000 |
| 24/10/21for Q3 2024 | Cornerstone Government Affairs | $90K |
| 24/10/18for Q3 2024 | Kyle House Group | Under $5,000 |
| 24/10/17for Q3 2024 | Forbes-Tate | Under $5,000 |
| 24/07/22for Q2 2024 | Cornerstone Government Affairs | $90K |
| 24/07/18for Q2 2024 | Kyle House Group | Under $5,000 |